Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10029001 | 0.98 | MAPK9 (0.33) | KDM4EALDH1A1MAPTHPGDMAPK8 | |
| SCHEMBL10028995 | 0.93 | CYP1A2 (0.35) | KDM4EALDH1A1HPGDERBB2CYP1A2 | |
| SCHEMBL10029009 | 0.91 | MAPT (0.32) | KDM4EALDH1A1MAPTHPGDCYP1A2 | |
| SCHEMBL10028988 | 0.87 | SIGMAR1 (0.36) | ALDH1A1HPGDERBB2CYP1A2FYN | |
| SCHEMBL10029002 | 0.85 | CHKA (0.35) | KDM4EMAPK14CYP1A2 | |
| SCHEMBL8051257 | 0.84 | KDM4E (0.35) | KDM4EALDH1A1MAPTHPGDCYP1A2 | |
| SCHEMBL12856568 | 0.84 | CYP1A2 (0.37) | KDM4EALDH1A1MAPTHPGDERBB2 | |
| SCHEMBL29721190 | 0.84 | CYP1A2 (0.37) | KDM4EALDH1A1MAPTHPGDERBB2 | |
| SCHEMBL13320933 | 0.84 | CYP1A2 (0.37) | KDM4EALDH1A1MAPTHPGDERBB2 | |
| SCHEMBL557051 | 0.84 | GSTP1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586211-B2 | Asymmetrical aryl amine derivative for organic electroluminescence devices, method for preparing same, organic thin film for organic electroluminescence devices and organic electroluminescence device using same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2013-11-19 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | AOC2, ALKBH2, ALKBH1 | KDM4E 516/4885ALDH1A1 122/4885MAPT 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.